For COPD patients with CB, bronchodilators with inhaled corticosteroids (ICSs) and/or phosphodiesterase-4 (PDE-4) inhibitors are currently recommended to reduce the frequency of exacerbations. Here, PDE4A is linked to chronic obstructive pulmonary disease.